Haleon Director Increases Stake
The retailer announces a director has purchased additional shares in the company.
The retailer announces a director has purchased additional shares in the company.
The consumer healthcare company outlines its 'Win as One' strategy, targeting 4-6% annual organic revenue growth and high-single digit adjusted operating profit growth.
The consumer healthcare company has appointed a new independent non-executive director with significant experience in the consumer goods and retail sectors.
The consumer healthcare company reports Q1 trading in line with expectations, providing limited details on performance.
The healthcare company has agreed to acquire the remaining 12% equity interest in its China joint venture, TSKF, for £0.2 billion, consolidating its position in the growing Chinese OTC market.
The healthcare company Haleon announced that two of its directors, the General Counsel and Chief Marketing Officer, have acquired additional shares in the company through its employee share plan.
The consumer healthcare company Haleon has announced details for its upcoming Annual General Meeting, including the date, time, and availability of meeting documents.
The major consumer healthcare company is launching a £330 million share buyback programme to enhance shareholder returns.
The healthcare company announces the sale of the entire residual stake held by major shareholder Pfizer Inc.
The consumer healthcare company has granted share awards to its senior management team under various incentive plans.